Leadership & Pay ·
SCYNEXIS, Inc. announced the retirement of Chief Financial Officer Ivor Macleod and the appointment of Sanjay…
SCYXScynexis Inc
SCYNEXIS, Inc. announced the retirement of Chief Financial Officer Ivor Macleod and the appointment of Sanjay Subramanian as his successor, effective September 9, 2026. Mr. Macleod will remain with the company through October 9, 2026 to facilitate a transition. Mr. Subramanian’s employment agreement includes an annual base salary of $500,000, a one-time sign-on bonus of $20,000, and a discretionary performance bonus of up to 40% of his base salary. He received a stock option to purchase 100,000 shares at an exercise price of $4.91 per share, vesting over four years. The agreement also outlines severance provisions, including nine months of base salary and accelerated equity vesting upon termination without cause or for good reason, increasing to eighteen months following a change of control. SCYNEXIS operates in the biotechnology industry, developing innovative therapies for severe rare diseases.